Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.
about
Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progressionRole of Natural Radiosensitizers and Cancer Cell Radioresistance: An UpdateTumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system.ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.Pathway-based evaluation in early onset colorectal cancer suggests focal adhesion and immunosuppression along with epithelial-mesenchymal transition.A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.DNA repair: the culprit for tumor-initiating cell survival?Increased expression of DNA repair genes in invasive human pancreatic cancer cells.Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancerTumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastasesEpithelial-mesenchymal transition in breast cancer progression and metastasis.Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancerShort-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis.Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.Understanding the colon cancer stem cells and perspectives on treatment.Role of inflammatory infiltrates in triple negative breast cancer.AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients.Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.Regulation of cancer stem cells by RING finger ubiquitin ligases.Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth.The mutually regulatory loop of epithelial-mesenchymal transition and immunosuppression in cancer progression.miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype.Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion.Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack.CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.[The roles of signal transducer and activator of transcription 3 in tumor metastasis].
P2860
Q24633879-72415B70-9B39-4542-BECD-7BA947D4E887Q26753100-7E41D88A-FBC1-4B6D-B12E-6FBD28A52D8DQ33668830-C2090D1B-0517-47F5-85E1-367B1B2DB8DAQ33757116-31458B9D-C51A-4178-B893-F0C2A8229F71Q34138282-6B7AB2E4-3C72-41AD-AAD1-C420FBF383ACQ34169228-4331A410-DEC2-4491-AF82-53E92FDF062FQ34229772-317D28F5-5279-4D26-B4DE-55EC8041F95EQ34395138-8706384B-C6E0-4FB8-9CE7-416E3492D252Q34804212-480310F3-BC2D-45D3-A1C2-8EEBE335111DQ35048189-CC02744F-6564-45D4-B273-85E4079CAFE5Q35762816-8ADEBF92-0CF5-4F7A-B079-4F0D96317FE7Q35858016-D0D9CA51-4D8E-4D33-B878-3B30A81BF1EDQ36015463-BCAD0597-CAE4-4C16-89A5-3FBDF7AF653EQ36343793-D80BA317-09B1-4181-9CAF-C6DC1A41746BQ36986452-5171DB98-2D5A-438E-B914-F767C9DA3B1FQ37320359-A6DCCE0D-9880-4592-BFA0-0CA091D9003FQ37323046-AD89E8FD-AC57-4452-A4BF-593D8F40A64DQ37330932-C4C543ED-A610-4C92-A441-15F8ADD4897EQ37621666-E9C6F207-9843-423D-B7E5-831C2AC5A773Q37885165-DB20CAF3-7F69-4137-8664-47D1DC673463Q37924873-BF073258-1AD6-49B6-AA73-6EA385E83843Q38023238-892667FD-CFFE-4C53-8E62-4E6AC7B67374Q38255668-8F04E2B9-3471-4E8A-9902-5B2F528E4A29Q38356774-B861C93A-E011-4E53-AEDF-F63336C982C3Q38370266-E5A11FDE-9F00-4394-9980-072ABD8CB2EEQ38672995-1A38F45F-4C0F-4131-ACFA-2B72FFEDB69EQ38721748-723050A2-BAAF-4E68-98FF-7587B82A66ADQ38743649-2D8BEEFE-D164-4214-8C73-4B461472D110Q38881445-A76B6F36-2186-4708-B1BC-E55974231939Q38984559-BDB00248-BD24-4DCB-9D7D-CC825F44063FQ41127008-8D2E50A6-C1C4-4D1D-B5A4-163235F2C544Q41593134-2F647DE1-A404-4BB2-B635-C388AAD46281Q42972451-39755263-3015-4F48-B7E9-0633FCC1ACDBQ48289081-6E1DCA63-54F7-4179-B7D7-C4CCE0D26F68Q50941364-7B565D45-671D-43A0-9AAB-6877E9166FEBQ54961074-0CBA2354-2923-4C78-BA92-B7C1ECC12ACEQ54974080-6EED6B29-E8CA-4244-8D3F-F6126122E5F1Q55168635-B9AC791D-F326-4BA4-941F-20DFAB56B3A8Q55465352-15F8DF71-E26E-4353-BFBC-F2E1DC9F7E06
P2860
Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immune promotion of epithelial ...... n of breast cancer stem cells.
@ast
Immune promotion of epithelial ...... n of breast cancer stem cells.
@en
type
label
Immune promotion of epithelial ...... n of breast cancer stem cells.
@ast
Immune promotion of epithelial ...... n of breast cancer stem cells.
@en
prefLabel
Immune promotion of epithelial ...... n of breast cancer stem cells.
@ast
Immune promotion of epithelial ...... n of breast cancer stem cells.
@en
P2860
P1433
P1476
Immune promotion of epithelial ...... on of breast cancer stem cells
@en
P2093
Derek C Radisky
Keith L Knutson
P2860
P304
P356
10.1158/0008-5472.CAN-09-4041
P407
P577
2010-04-01T00:00:00Z